Research Library / Article Summary

Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial

Plain-English AddictionTube research summary with source link, DOI, key finding, and recovery relevance.

Molecular Psychiatry • 12 Dec 2024 • Research

alcoholcravingrelapsetreatment

Research focus

This article may help explain addiction science through research on alcohol, craving, relapse, treatment. The source abstract begins by describing: “Although alcohol use disorder (AUD) is highly prevalent, only a few medications are approved for its treatment leaving much room for improvement.”

Key finding: Clinical Trials Registry: DRKS00029993.

Why this may help: This may help explain why addiction can involve brain, behavior, mental health, craving, relapse, or treatment factors rather than simple willpower alone. It should be read as research information, not personal medical advice.

Article details

Authors: Sina Zimmermann, Anton Teetzmann, Patrick Bach

DOI: 10.1038/s41380-024-02869-y

Open access: Open Access

Open original source article

Related article summaries

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study

This article may help explain addiction science through research on alcohol, dopamine, craving, relapse. The source abstract begins by describing: “Preclinical studies support an important role of dopamine D3 receptors (DRD3s) in alcohol use disorder (AUD).”

Key finding: Furthermore, the finding that binding in the SN is associated with alcohol demand warrants further examination.

Neuropsychopharmacology • 04 Aug 2021 • Research

alcoholdopaminecravingrelapsetreatment

Read plain-English summary Open source

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence

This article may help explain addiction science through research on cannabis, brain science, withdrawal, craving. The source abstract begins by describing: “Cannabis withdrawal in cannabis use disorder (CUD) increase the risk of relapse and lacks effective treatments.”

Key finding: Increases in FAAH (%ΔFAAH whole-brain) were significantly associated with longer cannabis abstinence, greater baseline depression severity, and tendency to act without thinking ( p

Neuropsychopharmacology • 09 May 2026 • Research

cannabisbrain sciencewithdrawalcravingrelapsemental health

Read plain-English summary Open source

Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum

This article may help explain addiction science through research on alcohol, cannabis, brain science, withdrawal. The source abstract begins by describing: “Alcohol use disorder (AUD) remains a pervasive public health issue with limited effective treatments.”

Key finding: These findings indicate that chronic CBD administration attenuates both behavioral and neurobiological facets of alcohol dependence by modulating neuronal excitability and preventing neurodegeneration, supporting its therapeutic potential for AUD and providing mechanistic insights for future research.

Neuropsychopharmacology • 10 Jul 2025 • Research

alcoholcannabisbrain sciencewithdrawalrelapsegenetics

Read plain-English summary Open source

Found in translation: orexin receptor antagonism for the treatment of opioid use disorder

This article may help explain addiction science through research on opioid, withdrawal, craving, relapse. The source abstract begins by describing: “Existing pharmacological treatment options for opioid use disorder (OUD) face challenges that limit their efficacy.”

Key finding: This review adopts a translational approach to achieve several aims: (1) to outline the fundamental theories of orexin system function and relate orexinergic dysfunction to the disordered motivation and withdrawal states that characterize OUD; (2) to provide an up-to-date evaluation of preclinical and clinical evidence bases supporting the efficacy of orexin receptor antagonism for the treatment of OUD; (3) to discuss key clinical considerations of repurposing DORAs for OUD treatment, including safety and side effects (i.e., respiratory depression, anhedonia, and risk for abuse); and (4) to highlight the ongoing clinical efforts to determine therapeutic efficacy and safety profiles of DORAs for use in OUD populations.

Translational Psychiatry • 24 Oct 2025 • Reviews

opioidwithdrawalcravingrelapsemental healthtreatment

Read plain-English summary Open source

Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking

This article may help explain addiction science through research on cocaine, brain science, craving, relapse. The source abstract begins by describing: “Cocaine use disorder represents a public health crisis with no FDA-approved medications for its treatment.”

Key finding: These findings suggest that gut bacteria, via their metabolites, are key regulators of drug-seeking behaviors, positioning the microbiome as a potential translational research target.

Neuropsychopharmacology • 02 Aug 2023 • Research

cocainebrain sciencecravingrelapsemental healthtreatment

Read plain-English summary Open source